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Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia character-
ized by excessive muscle activity and undesirable motor events during REM sleep. RBD
occurs in approximately 0.5% of the general population, with a higher prevalence in older
men. RBD is a frequent feature of dementia with Lewy bodies (DLB), but is only rarely
reported in Alzheimer’s disease. RBD is also a risk factor for α-synuclein-related diseases,
such as DLB, Parkinson’s disease (PD), and multiple system atrophy. Therefore, RBD has
major implications for the diagnosis and treatment of neurodegenerative disorders and for
understanding speciﬁc neurodegeneration patterns. Several markers of neurodegeneration
have been identiﬁed in RBD, including cognitive impairments such as deﬁcits in attention,
executive functions, learning capacities, and visuospatial abilities. Approximately 50% of
RBD patients present mild cognitive impairment. Moreover, RBD is also associated with
cognitive decline in PD.
Keywords: sleep, cognition, elderly, REM sleep behavior disorder, mild cognitive impairment, Parkinson’s disease,
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DESCRIPTION OF RBD
Rapid eye movement (REM) sleep behavior disorder (RBD) is a
parasomnia characterized by the presence of undesirable and often
violent motor manifestations during REM sleep, such as laugh-
ing, shouting, reaching, gesturing, arm ﬂailing, punching, kicking,
sitting up, or leaping out of bed (Schenck et al., 1986). These
behaviors are generally associated with dream contents: individ-
uals appear to act out their dreams. The violent nature of some
dream-enactment behaviors may cause severe injury to individ-
uals with RBD or their bed partners (Schenck et al., 2009). RBD
generally affects adults aged 50 years and over, with an estimated
prevalence of about 0.5% in the general population (Ohayon et al.,
1997). This rate may increase to about 7% in people aged 70 and
over (Boot et al., 2012). RBD is predominantly reported in men,
at a proportion of around 85% (Bodkin and Schenck, 2009). The
reasons for this gender disproportion remain unclear (selection
bias or a biological effect).
In normal individuals, muscular activity during REM sleep
is suppressed (atonia). In RBD, the mechanisms responsible
for atonia are altered, causing abnormally excessive chin or
limb electromyographic activity during REM sleep (Montplaisir
et al., 2010). This leads to the vigorous behavioral manifesta-
tions reported by patients and relatives, which can also be seen
on infrared videotape in a sleep laboratory. The RBD diagnosis
is conﬁrmed by polysomnographic recording, including analyses
of electromyographic activity during REM sleep (American Acad-
emy of Sleep Medicine, 2005). Polysomnographic recording has
the additional advantage of eliminating other sleep disorders that
are confused with RBD, such as somnambulism or moderate to
severe sleep apneas. Questionnaires are also available for assessing
clinical RBD (Li et al., 2010; Boeve et al., 2011). For treatment of
RBDsymptoms,clonazepamandmelatonin are the twomost com-
monly used pharmacological agents (Gagnon et al., 2006a; Aurora
et al., 2010). Changing the sleep environment is also recommended
to prevent injuries to the patient and the bed partner. Although
the pathophysiology of RBD in humans is still debated, anomalies
in the pontomedullary brainstem neural networks responsible
for the suppression of muscle tone during REM sleep (i.e., the
sublaterodorsal nucleus or coeruleus/subcoeruleus complex) are
strongly suspected (Boeve et al., 2007; Luppi et al., 2011).
RBD SUBTYPES
There are different forms of RBD. The acute form is triggered by
certain psychotropic drugs (pharmacology-induced RBD), such as
antidepressants (Gagnon et al., 2006a). RBD is also strongly asso-
ciated with certain neurological disorders (symptomatic RBD),
including narcolepsy, Machado–Joseph disease, amyotrophic lat-
eral sclerosis, epilepsy, multiple sclerosis, and Guillain–Barre syn-
drome (Gagnon et al., 2006b; Iranzo et al., 2009). Symptomatic
RBD can also be induced by focal lesions (vascular or inﬂam-
matory), tumors, or neurodegenerative processes in brainstem
regions responsible for normal REM sleep muscle atonia (Gagnon
et al., 2006b; Iranzo et al., 2009; Limousin et al., 2009). In fact,RBD
is very frequent in synucleinopathies, a class of neurodegenera-
tive diseases characterized by abnormal deposition of α-synuclein
proteins. For instance, RBD affects about 33–46% of patients with
Parkinson’s disease (PD; Gagnon et al., 2002; Sixel-Döring et al.,
2011), 75% of patients with dementia with Lewy bodies (DLB;
Ferman et al., 2011), and almost 100% of patients with multiple
system atrophy (MSA; Vetrugno et al., 2004). Synucleinopathies
share a common brainstem neurodegeneration with RBD, which
may explain their strong association. On the other hand, RBD is
rare in tau-related diseases such as Alzheimer’s disease (AD), pro-
gressive supranuclear palsy, corticobasal degeneration, and fron-
totemporal dementia (Gagnon et al., 2006b; Iranzo et al., 2009).
RBD is therefore a useful feature to consider for differential diag-
nosis between DLB and AD. In fact, inclusion of RBD as a core
clinical feature improves the DLB diagnosis accuracy (Ferman
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et al., 2011). Finally, RBD can appear alone (“idiopathic” RBD
or iRBD) without any associated condition (Gagnon et al., 2006b;
Iranzo et al., 2009). However, the term “idiopathic” is subject to
challenge because iRBD may be a risk factor for synucleinopathies
(Fantini et al., 2005; Ferini-Strambi, 2011).
“IDIOPATHIC” RBD AS A RISK FACTOR FOR
SYNUCLEINOPATHIES
Three longitudinal studies performed in a sleep disorders center
found that RBD is a signiﬁcant risk factor for developing synu-
cleinopathies. Schenck et al. (1996) reported in 29 iRBD patients
that 38%hadparkinsonism3.7 years after RBDdiagnosis.Another
study in 44 iRBD patients found that 36% developed a synucle-
inopathy 5.1 years following RBD diagnosis (Iranzo et al., 2006).
Of the converted patients, 56% developed PD, 38% DLB, and one
patient developed MSA. Four additional patients with iRBD met
the criteria for mild cognitive impairment (MCI) at follow-up. In
2009, our group published the follow-up results on a large cohort
of 93 patients with iRBD: 28% developed a neurodegenerative
disease 4.8 years following RBD diagnosis (Postuma et al., 2009a).
Of the diseased patients, 54% developed PD, 42% DLB, and one
patient developed MSA. Using a life table (survival) analysis, the
risk for developing a synucleinopathy in iRBD patients was esti-
mated at 18% after 5 years, 41% after 10 years, and 52% after 12
years (Postuma et al., 2009a).
In the only population-based study to date, Boot et al. (2012)
followed 651 cognitively intact participants, including 44 individ-
uals with baseline clinical iRBD. After a median of 3.8 years, only
2% of iRBD patients developed PD, whereas 32% met MCI crite-
ria. Although the conversion rate was far lower than in previous
clinical studies, the iRBD patients had a 2.2-fold increased risk of
developing MCI or PD over non-RBD patients. A potential expla-
nation for the link between RBD symptoms and the development
of synucleinopathies comes from studies on the pathological pro-
gression of synucleinopathies (Braak et al., 2003; Halliday et al.,
2011). In the ﬁrst stages, before clinical motor symptoms appear,
Lewy bodies and Lewy neuritis can be found in brainstem areas
involved in RBD pathophysiology. The gradual progression of the
neurodegeneration to more rostral brain structures would subse-
quently cause symptoms characteristic of synucleinopathies. This
may explain why RBD is an early symptom in certain patients
with synucleinopathies. These results show the importance of
performing neurological and neuropsychological assessments to
detect early signs of a synucleinopathy or MCI in iRBD patients,
particularly for those referred to a sleep disorders center.
MARKERS OF NEURODEGENERATION IN “IDIOPATHIC” RBD
Severalmarkers of synucleinopathies have been identiﬁed in iRBD.
Recent studies have reported that the severity of the loss of
REM sleep muscle atonia (Postuma et al., 2010), olfaction and
color vision impairments (Postuma et al., 2011a), substantia nigra
hyperechogenicity, and decreased striatal dopamine transporters
uptake (Iranzo et al., 2010a) can predict the development of
synucleinopathies in iRBD (Postuma et al., 2011b). Other stud-
ies have found cognitive (Ferini-Strambi et al., 2004; Gagnon
et al., 2009), subtle motor (Postuma et al., 2009b), waking EEG
(Fantini et al., 2003), autonomic (Miyamoto et al., 2006; Pos-
tuma et al., 2009b), and functional and structural neuroimag-
ing (Unger et al., 2010; Hanyu et al., 2011; Scherﬂer et al.,
2011; Vendette et al., 2011) anomalies in iRBD, similar to those
reported in synucleinopathies (Gagnon et al., 2006b; Postuma
et al., 2011b).
COGNITIVE DECLINE IN RBD
POOR COGNITIVE PERFORMANCE IN “IDIOPATHIC” RBD
Increasing evidence shows that iRBD patients perform poorly on
neuropsychological tests (Ferini-Strambi et al., 2004; Massicotte-
Marquez et al., 2008; Terzaghi et al., 2008; Gagnon et al., 2009;
Marques et al., 2010; Fantini et al., 2011). However, results vary
across studies depending on which cognitive domain is impaired
(Table 1). Population heterogeneity, small sample size, and the
use of different cognitive tasks with variable sensitivity to detect
deﬁcits and variable speciﬁcity to a cognitive domain may explain
these discrepancies. In general, attention, executive functions,
episodic verbal memory (mainly free recall capacities), and non-
verbal learning are the most affected domains in iRBD (Ferini-
Strambi et al., 2004; Massicotte-Marquez et al., 2008; Terzaghi
et al., 2008; Gagnon et al., 2009; Marques et al., 2010; Fantini et al.,
2011). Additionally, some studies reported in iRBD anomalies in
visuospatial/visuoperceptive abilities (Ferini-Strambi et al., 2004;
Iranzo et al., 2010b; Marques et al., 2010; Fantini et al., 2011),
but this remains controversial (Massicotte-Marquez et al., 2008;
Terzaghi et al., 2008; Gagnon et al., 2009). In fact, the presence
of visuospatial (or non-verbal learning) impairment appears to
be related to the extent of cognitive decline in iRBD patients
(Iranzo et al., 2006; Molano et al., 2010; Fantini et al., 2011),
as reported in RBD-associated neurodegenerative diseases such
as PD or DLB (Ferman et al., 2002; Gagnon et al., 2009). On
the other hand, language and praxis appear to be well preserved
in iRBD, although these functions have received little research
attention.
Table 1 | Controlled studies on cognitive performance in “idiopathic” rapid eye movement sleep behavior disorder.
Cognitive domains Terzaghi
et al. (2008)
Massicotte-Marquez
et al. (2008)a
Gagnon
et al. (2009)a
Marques
et al. (2010)
Ferini-Strambi
et al. (2004)b
Fantini et al.
(2011)b
Attention/executive functions Yes Yes Yes Yes Yes No
Verbal episodic memory Yes Yes Yes Yes Yes Yes
Non-verbal memory Yes – – – Yes Yes
Visuospatial abilities No No No Yes Yes Yes
a,bShare common participants; Yes=patients show poorer performance than controls (p<0.05); No= similar performance between patients and controls.
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Box 1 Case report.
Mister X is a 62-year-old man referred to a memory clinic for cognitive assessment. He complains about his reduced abilities to concen-
trate and recall information. The scan is normal. No vascular risk factors or major psychiatric symptoms are found. The neuropsychological
exam shows mild deﬁcits in cognitive tests assessing attention and episodic verbal memory (affected free recall capacities with preserved
recognition). Daily life activities are reported as satisfactorily accomplished. Based on this clinical proﬁle, Mister X meets the criteria for mild
cognitive impairment.When questioned about his sleep, he reports the presence of violent behaviors associated with vivid dreams. His wife
conﬁrms this and reports that she sleeps in a separate bed to avoid potential injury. Mister X is referred to a sleep disorders center to conﬁrm
a diagnosis of rapid eye movement (REM) sleep behavior disorder (RBD). The polysomnographic recording shows excessive chin muscle
tone during REM sleep with no other anomalies.When these results are combined with the reports of dream-enactment behaviors, Mister
X meets the RBD diagnosis criteria. Unfortunately, subsequent assessments at the memory clinic reveal cognitive decline, particularly in
executive functions and visuospatial abilities. In addition, at the last visit, the patient reports a signiﬁcant impact of the cognitive impairment
on his daily life activities and shows signs of parkinsonism. The diagnosis of probable dementia with Lewy bodies is conﬁrmed.
MCI IN “IDIOPATHIC” RBD
Mild cognitive impairment is known to be an intermediate state
between normal cognitive functioning and dementia (Gauthier
et al., 2006). MCI can be diagnosed according to the follow-
ing criteria: (1) subjective cognitive complaint by the patient
or a relative, (2) cognitive decline on neuropsychological testing
compared to age- and education-equivalent individuals, and (3)
preserved daily life activities (Gagnon et al., 2009; Albert et al.,
2011). MCI can be subdivided into different subtypes according
to the number (single-domain vs. multiple-domain) and nature
(amnestic vs. non-amnestic) of the cognitive domains impaired
(Petersen and Morris, 2005). MCI is a risk factor for demen-
tia such as AD, DLB, or vascular dementia (Gauthier et al.,
2006). However, the progression of MCI is also highly vari-
able. Some MCI patients remain with mild cognitive deﬁcits
for many years whereas a substantial proportion return to nor-
mal cognitive functioning (Ganguli et al., 2004; Gauthier et al.,
2006; Fischer et al., 2007). Moreover, several factors may dis-
rupt cognition in elderly individuals, including psychiatric symp-
toms,medication side effects, respiratory conditions (sleep apneas,
chronic obstructive pulmonary disease), and vascular diseases.
Consequently, clinicians and researchers should be careful not to
directly link MCI to the future development of a neurodegener-
ative disease or to consider MCI as part of a neurodegenerative
disease.
Mild cognitive impairment is a frequent feature of iRBD
(Iranzo et al., 2006; Gagnon et al., 2009; Molano et al., 2010). In
iRBD patients referred to a sleep disorders center, MCI frequency
was estimated at up to 50% compared to 8% in healthy subjects
(Gagnon et al., 2009). The main MCI subtype reported was non-
amnestic MCI single-domain with predominant attention and
executive dysfunctions. No study to date has systematically fol-
lowed a large cohort of iRBD patients with MCI to determine the
risk of developing dementia. However, Molano et al. (2010) fol-
lowed seven iRBD patients for many years. All patients met MCI
criteria and subsequently developed Lewy body disease, which was
conﬁrmed by autopsy. This suggests that iRBD patients with MCI
are at higher risk for developing DLB.
COGNITIVE DECLINE IN PD ASSOCIATED WITH RBD
A substantial proportion of PD patients have cognitive impair-
ment, andmore than 50%will develop dementia during the course
of PD (Aarsland and Kurz, 2010). As mentioned above, RBD is
also a frequent feature of PD (Gagnon et al., 2002; Sixel-Döring
et al., 2011). RBD in PD patients has been associated with cog-
nitive impairment (Sinforiani et al., 2006; Vendette et al., 2007;
Gagnon et al., 2009; Naismith et al., 2011), waking EEG slowing
(Gagnon et al., 2004), a predominance of akinetic-rigid signs (Pos-
tuma et al., 2008), symmetric disease (Bliwise et al., 2010), visual
hallucinations (Pacchetti et al., 2005), and autonomic dysfunc-
tion (Postuma et al., 2009b, 2011c). Our team found a higher
risk of having MCI in PD with concomitant RBD: MCI was
present in 73% of PD patients with RBD compared to 11% of PD
patients without RBD and 8% of healthy controls (Gagnon et al.,
2009). Moreover, we recently conducted a prospective follow-up
study in a cohort of PD patients to assess whether the presence
of polysomnographic-conﬁrmed RBD at baseline predicted the
future development of dementia according to neurological and
neuropsychological assessments (Postuma et al., 2012). The sam-
ple comprised 42 PD patients without dementia, including 27 with
RBD and 15 without RBD. Over a mean 4-year follow-up, 48%
of PD patients with RBD developed dementia, whereas none of
PD patients without RBD converted to dementia. Although these
results remain to be conﬁrmed in a larger cohort of PD patients,
they suggest that the presence of RBD in PD could indicate
a more devastating and wide-spread neurodegenerative disease
compared to PD patients without RBD symptoms (Postuma et al.,
2012).
CONCLUSION
Box 1 summarizes a case report of an individual referred to a
memory clinic for cognitive decline and subsequently diagnosed
with RBD. This case shows the importance of identifying RBD
in patients with cognitive impairment. A better understanding of
this sleep disorder would enable a deeper grasp of the underlying
pathophysiology and diagnosis of synucleinopathies, and would
contribute to the development of neuroprotective treatments.
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